NCT00403273View on ClinicalTrials.gov

Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA)

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Knee Pain
Interventions
DRUG

Botulinum toxin A

100 units of Botulinum toxin A in 5 cc of normal saline in the Painful TKA at screening visit

DRUG

Normal Saline

Single Intra-articular Injection of 5 cc of normal saline in the Painful TKA at screening visit

Trial Locations (1)

55417

Minneapolis VA Medical Center, Minneapolis

Sponsors

Collaborators (1)

Arthritis Foundation
All Listed Sponsors
collaborator

University of Minnesota

OTHER

collaborator

Arthritis Foundation

OTHER

lead

Minneapolis Veterans Affairs Medical Center

FED